PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
基本信息
- 批准号:10670915
- 负责人:
- 金额:$ 102.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-20 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventAfrican American populationAgeAge related macular degenerationAgingAlzheimer&aposs DiseaseAmerican Medical AssociationAncillary StudyAndrogen MetabolismAtrophicBiologicalBiopsyBloodCancer Prevention TrialCancer Research InfrastructureCardiovascular systemCataractCause of DeathCessation of lifeClinicalClinical Trials DesignCollaborationsColoradoColorectalColorectal CancerColorectal PolypCountryDataData CollectionData ElementData LinkagesData SetDatabasesDiagnosisDietDiseaseDocumentationDouble-Blind MethodDouble-blind trialEligibility DeterminationEtiologyFinasterideFundingGenotypeGrantIncidenceInflammationInfrastructureInstitutionInsulin ResistanceJournalsLeukocytesLife StyleMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMeasuresMedical HistoryMedicareMedicineMinorityNational Clinical Trials NetworkNew EnglandParticipantPathologyPharmaceutical PreparationsPhasePhysical activityPlacebo ControlPlacebosPlasmaProceduresPrognosisProgram Research Project GrantsProstateProstate Cancer Prevention TrialProstate-Specific AntigenPublicationsPublishingQuality of lifeRandomizedRectumReportingResearch DesignResearch PersonnelRespiratory physiologyRiskRisk FactorsSamplingScheduleScreening for Prostate CancerSecureSeleniumSelenium and Vitamin E Efficacy TrialSerumSouthwest Oncology GroupSpecimenStructure of nail of toeTissue BanksTissue SampleTissuesUnited StatesUniversitiesUpdateVisitVitamin EWashingtonanticancer researcharmbiobankcancer diagnosiscancer epidemiologyclinical databasecohortdata dictionarydata repositorydata sharingdietary supplementsdigitalepidemiology studyfollow-upgenetic associationgenome wide association studygenome-wideindexinglower urinary tract symptomsmalemembermenoxidative damageplacebo controlled studyplacebo groupprospectiveprostate biopsyprostate cancer riskrandomized trialrandomized, clinical trialsrectalrepositorysecondary endpointstatistical centeruser-friendly
项目摘要
PROJECT SUMMARY/ABSTRACT
The SWOG Statistical Center in Seattle, Washington, served as the coordinating center for two large prostate
cancer prevention trials: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) and the Prostate
Cancer Prevention Trial (PCPT). SELECT was a Phase III, double-blind, placebo-controlled study designed to
assess the effect of selenium and vitamin E, alone and in combination, primarily on prostate cancer incidence
and secondarily on other cancer incidence. SELECT randomized 35,533 men between 2001 and 2004. PCPT,
also a Phase III, double-blind trial, randomized 18,882 men to either finasteride or placebo between 1994 and
1997. Although schedules and requirements varied between the two studies, substantial serum, plasma, white
blood cells, and prostate tissue were collected on both, resulting in rich biorepositories.
Each had extensive prospective data collections which included diet and dietary supplements, quality of life,
physical activity, medications, other cancer diagnoses, cardiovascular endpoints, and treatment adverse events.
Although there have been significant scientific collaborations to date, there remain numerous opportunities to
further interrogate the clinical database and biobanks. Additionally, serum and plasma measures and extensive
genotyping data have already been obtained and are available for other investigators to use.
These cohorts are fully mature with 6,045 deaths and median follow-up of 18.4 years on PCPT and 3,762 deaths
and median follow-up of 10.1 years on SELECT. There have been 2,401 and 2,475 prostate cancers detected
during the trials plus an additional 890 and 338 prostate cancers identified via Medicare linkage in PCPT and
SELECT, respectively. Other primary cancers have also been documented either during the trials or through
data linkage. In addition to being able to extend the results of these well-conducted, randomized clinical trials
through linkages to Medicare, NDI and completed GWAS studies, these data can be used for epidemiologic
research as part of the ongoing consortium projects.
We request funds to continue to enrich the cohorts by collecting new data elements such as end point data from
Medicare and National Death Index linkages. We plan to update our linkages early in the upcoming grant period.
We also request support for the cohort team to develop detailed documentation and data sets to load into the
Cancer Epidemiology Data Repository, and we ask for continued support to provide a stable infrastructure for
the PCPT serum and PCPT and SELECT tissue repositories (all located at the University of Colorado). With
continued funding for the Statistical Center and some of our key scientific colleagues, we will be able to provide
administrative assistance and expertise to investigators who apply for additional funding to conduct studies using
our rich biologic repositories and clinical databases from PCPT and SELECT.
项目摘要/摘要
位于华盛顿州西雅图的SWOG统计中心作为两个大前列腺的协调中心
癌症预防试验:硒和维生素E癌症预防试验(SELECT)和前列腺癌
癌症预防试验(PCPT)。SELECT是一项第三阶段的双盲安慰剂对照研究,旨在
评估单独和联合应用硒和维生素E对前列腺癌发病率的影响
其次是其他癌症发病率。选择2001至2004年间随机抽取的35,533名男性。PCPT,
同样是一项第三阶段的双盲试验,在1994至1994年间,随机选择18,882名男性服用非那雄胺或安慰剂。
1997年。尽管两项研究的时间表和要求不同,但大量的血清、血浆、白蛋白
血细胞和前列腺组织都被收集在两者上,从而产生了丰富的生物库。
每个人都有广泛的前瞻性数据收集,包括饮食和膳食补充剂,生活质量,
体力活动、药物、其他癌症诊断、心血管终点和治疗不良事件。
尽管到目前为止已经有了重大的科学合作,但仍然有许多机会
进一步询问临床数据库和生物库。此外,血清和血浆测量和广泛的
基因分型数据已经获得,并可供其他调查人员使用。
这些队列完全成熟,有6045人死亡,PCPT的中位随访时间为18.4年,3762人死亡
SELECT的中位随访期为10.1年。已发现2401例和2475例前列腺癌
在试验期间,另外还有890例和338例前列腺癌是通过PCPT和
分别选择。其他原发癌症也被记录在试验期间或通过
数据链接。除了能够扩展这些进行得很好的随机临床试验的结果
通过与Medicare、NDI和已完成的Gwas研究相联系,这些数据可用于流行病学
作为正在进行的联合体项目的一部分进行研究。
我们要求资金继续通过收集新的数据元素来丰富队列,例如来自
医疗保险和国家死亡指数的联系。我们计划在即将到来的赠款期间早期更新我们的联系。
我们还请求支持队列团队开发详细的文档和数据集,以加载到
癌症流行病学数据库,我们要求继续支持,为以下项目提供稳定的基础设施
PCPT血清和PCPT以及精选组织库(均位于科罗拉多大学)。使用
继续为统计中心和我们的一些关键科学同事提供资金,我们将能够提供
向申请额外资金进行研究的调查人员提供行政援助和专业知识
我们丰富的生物资料库和来自PCPT和SELECT的临床数据库。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning Model.
- DOI:10.1016/j.euf.2021.11.009
- 发表时间:2022-09
- 期刊:
- 影响因子:5.4
- 作者:Perera, Marlon;Smith, Lewis;Thompson, Ian;Breemer, Geoff;Papa, Nathan;Patel, Manish I.;Swindle, Peter;Smith, Elliot
- 通讯作者:Smith, Elliot
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IAN M. THOMPSON其他文献
IAN M. THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IAN M. THOMPSON', 18)}}的其他基金
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
- 批准号:
10460634 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
- 批准号:
10227705 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
Enhancing the PCPT/SELECT cohorts Core Infrastructure Grant to support studies evaluating dietary supplement use and disease risk
加强 PCPT/SELECT 队列核心基础设施拨款,以支持评估膳食补充剂使用和疾病风险的研究
- 批准号:
9413226 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
- 批准号:
8634305 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
- 批准号:
10601377 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
- 批准号:
8738631 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
PCPT and SELECT cohorts: Core Infrastructure Support for Cancer Research
PCPT 和 SELECT 队列:癌症研究的核心基础设施支持
- 批准号:
9339971 - 财政年份:2013
- 资助金额:
$ 102.52万 - 项目类别:
Improving prostate biopsy efficiency: The finasteride challenge test
提高前列腺活检效率:非那雄胺激发试验
- 批准号:
8137196 - 财政年份:2010
- 资助金额:
$ 102.52万 - 项目类别:
Improving prostate biopsy efficiency: The finasteride challenge test
提高前列腺活检效率:非那雄胺激发试验
- 批准号:
7987292 - 财政年份:2010
- 资助金额:
$ 102.52万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 102.52万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 102.52万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 102.52万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 102.52万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 102.52万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 102.52万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 102.52万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 102.52万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 102.52万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 102.52万 - 项目类别: